Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of GSK3862995B in adults with non-cystic fibrosis bronchiectasis
CTR20254180Phase 2Active
- Sponsor
- GSK
- Start
- Dec 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of gsk3862995b in bronchiectasis, sponsored by GSK. Started Dec 2025; status: active.
02
Drugs
gsk3862995b
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20254180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254180.